Retrospective study on effect of rheumatic immune related antibodies on
clinical manifestation and cerebrospinal fluid characteristics of
neuromyelitis optic spectrum disorders
Abstract
Objective: To investigate that how the effect of rheumatic immune
antibodies on clinical manifestation and cerebrospinal fluid
characteristics of neuromyelitis optic spectrum disorders (NMOSD).
Methods: All 35 patients with NMOSD in the Second Hospital, Cheeloo
College of Medicine, Shandong University from 2017 to 2019 were
retrospectively reviewed. All patients underwent examination of serum
ANA, dsDNA, SS-A, SS-B,Ro-52 , AMA M2, Jo-1, PM-Scl, Scl-70, Sm and et
al. 6 positive-autoantibody patients are compared with 29
negative-autoantibody patients in gender, onset age, duration, number of
attacks, EDSS, initial presentation (on, spinal cord or brain), CSF WBC,
protein, Oligoclonal band and MBP. Results: The 6 NMOSD patients with
all AQP4-IgG positive had positive autoantibodies (17.1%), with no
diagnose as CTD. The frequency of SSA in the positive group was 50%,
while Ro-52 was 75%, AMA-M2 was 33%, ANCA-PR3 was 17%, and AHA was
17%. They were significantly higher in NMOSD patients with auto-immune
antibodies positive than those without auto antibodies
(P<0.05). EDSS scores were positively correlated with two
groups (NMOSD with or without auto antibodies). The positive group had
much more EDSS scores than the negative group. The number of CSF cells
in positive group was basically in normal range, median was 2.5x106.
Median of CSF protein was 866mg/L, which was much higher than negative
group. Conclusions: NMOSD patients with positive autoantibodies tends to
be more frequent in the patients with AQP4-IgG, who have more severe
intrathecal autoimmune inflammatory and disability. So they might need
more intensive treatment in the future.